Robert W. Anderson

Director/Board Member at Humacyte Global, Inc.

86 year

Consumer Services

Commercial Services

Health Technology

Profile

Robert W.
Anderson is currently a Director at Humacyte Global, Inc. He previously worked as a Director at MicroIslet, Inc. Anderson received his undergraduate degree from Duke University and his MBA and doctorate degrees from Northwestern University.

Robert W. Anderson active positions

Companies	Position	Start
Humacyte Global, Inc. Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC.	Director/Board Member	2004-12-31

All active positions of Robert W. Anderson

Former positions of Robert W. Anderson

Companies	Position	End
MicroIslet, Inc. MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA.	Director/Board Member	-

See the detail of Robert W. Anderson's experience

Training of Robert W. Anderson

Duke University	Undergraduate Degree
Northwestern University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert W. Anderson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
MicroIslet, Inc. MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA.	Commercial Services
Humacyte Global, Inc. Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC.	Health Technology